Being an ethical company is about much more than simply adhering to the letter of the law—but that’s an important step.
As part of our long-standing commitment to ethics and good corporate citizenship, our first step is always to comply with the laws and regulations that govern the way we market and sell our medicines, vaccines and other products. We have a well-established global compliance program that is consistent with the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) Code of Practice requirements, as well as other applicable regional or country industry codes of conduct, including those issued by the Pharmaceutical Research and Manufacturers of America (PhRMA) and European Federation of Pharmaceutical Industry Associations (EFPIA).
The global compliance program is built around the core elements of an effective compliance program:
Merck’s Board of Directors and senior management, including the Chief Ethics and Compliance Officer and members of the Corporate Compliance Committee, provide the foundational elements of leadership, accountability and structure to oversee the company’s global compliance program. Written standards, including a corporate code of conduct, compliance-related policies and procedures, education, training and communications, reinforce the importance of ethical and compliant business practices.
The Corporate Compliance Committee meets on a quarterly basis with each division to assess the effectiveness of its compliance program.
Last Updated April 21, 2014